The leading Metastatic Pancreatic Cancer Companies such as Xencor, MEI Pharma, Celldex Therapeutics, TG Therapeutics, ...

Pelareorep plus chemotherapy with or without Tecentriq had an acceptable safety profile in patients with newly diagnosed ...

Prostate cancer has a tendency to spread to the bones, specifically the pelvis, upper legs, and lower spine. While those are the most common sites for prostate cancer bone metastasis, any bones in ...

Dual luciferase reporter assays and chromatin immunoprecipitation were performed to identify whether SMAD4 functioned as a transcription factor for phosphoglycerate kinase 1 (PGK1) in PDAC cells.

Unlike historically established PDAC cancer cell lines, patient-derived models recapitulated the histological architecture of the primary tumour and exhibited metastatic spread similar to that ...

Adding telotristat ethyl to chemotherapy may result in weight stabilization in patients with metastatic pancreatic ductal adenocarcinoma (PDAC) and cachexia, according to findings from a phase 2 study ...

CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, P. R. China ...

Preliminary safety, antitumor activity, and circulating tumor DNA (ctDNA) changes with RMC-9805, an oral, RAS(ON) G12D-selective tri-complex inhibitor in patients with KRAS G12D pancreatic ductal ...

treatment of metastatic pancreatic adenocarcinoma (mPDAC) with FOLFIRINOX (FFX), FFX without 5FU bolus, and gemcitabine+nab-paclitaxel (GnP). Changes in peri-operative chemotherapy and radiation use ...

But for those diagnosed with Metastatic Breast Cancer (MBC), the challenges can be even more daunting. MBC is an advanced form of breast cancer that can spread from the breast to other parts of ...